Golden Tiger Pain Relief Cream Recalled for Out-of-Specification Ingredients
ARG Laboratories is recalling Golden Tiger Natural Pain Relieving Cream nationwide due to an active ingredient that does not meet specifications and violative grade propylene glycol used during manufacturing.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves out-of-specification active ingredient and violative-grade manufacturing component in a topical drug product, representing a quality and safety risk. No illnesses or injuries have been reported, but the defect creates a risk-of-harm scenario that warrants this classification.
Plain-English summary
Golden Tiger Natural Pain Relieving Cream (Camphor 3%, Menthol 3%) enriched with Capsaicin, Aloe Vera, Willow Bark, and MSM is being recalled by manufacturer ARG Laboratories, Inc. The product is sold in 32 fl oz bottles with pump dispenser (UPC 1 82294 00004 8).
The recall was issued because the active ingredient does not meet specifications and a violative grade of propylene glycol was used during the manufacturing process. These manufacturing defects may compromise the product's intended formulation and safety.
The affected product was distributed nationwide in the United States. Affected lot numbers are 01823C2 and 01823C1, both with expiration date 01/31/2025. Consumers who have purchased this product should stop using it and contact the manufacturer for instructions on product return or refund.
The recalled product
- Product
- NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%)Enriched with Pump Capsaicin, Aloe Vera, Willow Bark & MSM, Bottle with Pump NET WT 32 fl. oz (946.33ml), Manufactured for Golden Tiger LLC Made in USA, UPC 1 82294 00004 8
- Manufacturer
- ARG Laboratories, Inc.
- Category
- Drug — Topical Pain Relief
- Hazard
- out-of-spec-active-ingredient
- ingredient-contamination
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot 01823C2
- 01823C1
- Exp 01/31/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27